Cardiovascular Business

Cardiovascular Business Digital Editor Dave Fornell at #TCT2024, ran into Clyde W. Yancy, MD, MSc, vice dean for diversity and inclusion, chief of cardiology in the Department of Medicine, and a professor of medicine in cardiology and medical social sciences at Northwestern Medicine. Yancy is a big advocate for health equity and diversity and even promotes these areas as a business model. Here is an interview they did together on the subject - https://lnkd.in/gkiKKfRP

Example of the CathWorks fractional flow reserve angiography (FFR-Angio) on display in partner booth Medtronic at #TCT2024. The system uses a contrast injection and a rotation of the C-arm to reconstruct the FFR without the need for a pressure wire to help speed PCI procedures and help with guidance.

The Evoque TTVR system from Edwards Lifesciences, the first FDA-approved device of its kind, is associated with a much better quality of life than medical therapy alone after one year. Cardiologist Suzanne V. Arnold, MD, presented the late-breaking data at TCT in Washington, D.C.

#TAVR with a balloon-expandable valve from Edwards Lifesciences is safer and more effective than surgery for women with symptomatic, severe AS, according to a new pooled analysis presented at #TCT2024 in Washington, D.C.

Blood flow computer modeling inside the heart to check if there is flow into the left atrial appendage (LAA) that has been occluded using an Amulet device. Shown by the vendor Virtonomy.io at #TCT2024.

Peter Monteleone, MD, an interventional cardiologist, director of the interventional cardiology fellowship program at Ascension Texas Cardiovascular, national director of cardiovascular research at Ascension Health, ran into Cardiovascular Business Digital Editor Dave Fornell today. Monteleone is an expert in pulmonary embolism (PE) interventions. He and Fornell recorded a few interviews earlier this year on various aspects of PE: Interventional cardiology sees growing role in pulmonary embolism interventions -- https://lnkd.in/g3XiT8vc. A cardiologist's guide to treating pulmonary embolism — https://lnkd.in/g29hA7gv #TCT2024

The Protego cath lab radiation protection system displayed in the Siemens Healthcare booth at #TCT2024. This was one of several rad protection systems on the expo floor.

The Abbott Esprit BTK bioresorbable stents for use in peripheral arteries below the knee on display at #TCT2024. The BTK environment is hostile to stenting, but the bioresorbable stent offers an option to stent lesions and allows the vessel to heal and the stent will completely dissolve within 3 years. It was approved by the FDA in April 2024, read more — https://lnkd.in/gTRUa67x

Treating AMI patients with colchicine is not associated with better cardiovascular outcomes, according to new data presented at #TCT2024. The drug did help with inflammation, but that was the only benefit researchers could identify.

The Impella ECP from Abiomed a part of Johnson & Johnson MedTech, measures at just 3 mm in length. The device was linked to positive safety data in a new study presented at TCT 2024.